|
|
|
|
|
|
|
J Pediatr 2010,May,01;156(5):749-54; (PMID: 20171653)
OBJECTIVE: To investigate the effect of montelukast on eosinophil degranulation and recurrent wheezing episodes in post-respiratory syncytial virus (RSV) bronchiolitis. STUDY DESIGN: Two hundred infants (age, 6-24 months) who were hospitalized with their first episode of acute RSV [...]
|
|
|
Am J Clin Nutr 2010,May,01;91(5):1255-60; (PMID: 20219962)
[...] supplements (RR: 0.36; 95% CI: 0.17, 0.79; P = 0.006) and who started nursery school after age 3 y (RR: 0.36; 95% CI: 0.17, 0.78; P = 0.005). In children with a previous diagnosis of asthma, asthma attacks as a secondary outcome occurred in 2 children receiving vitamin D(3) compared with 12 children[...]
|
|
|
Ann Allergy Asthma Immunol 2010,May,01;104(5):420-5; (PMID: 20486333)
BACKGROUND: Previous Food and Drug Administration (FDA)-approved enzyme-linked immunosorbent assay testing of Dermatophagoides pteronyssinus diagnostic extracts showed potencies of 36% to 44% for 3 European extracts relative to the FDA standard (10,000 AU/mL).[...]
|
|
|
Ann Allergy Asthma Immunol 2010,May,01;104(5):452-3; (PMID: 20486338)
|
|
|
Ann Allergy Asthma Immunol 2010,May,01;104(5):440-9; (PMID: 20486336)
[...]BACKGROUND: Nighttime allergen exposures are a primary contributor to the development of allergic and asthmatic morbidities. Disease management guidelines recommend the use of environmental control measures to reduce these exposures, but clinically relevant reductions are difficult to achieve because most measures control only 1 allergen source among many in the bedroom environment.[...]
|
|
|
J Asthma 2010,May,01;47(4):400-6; (PMID: 20528593)
BACKGROUND: Small airways inflammation in asthma has been supposed to contribute to instability of the disease and therapy resistance. This study was designed to determine the validity of measurement of [...]
|
|
|
J Asthma 2010,May,01;47(4):429-33; (PMID: 20528598)
[...]sodium cromoglycate alone, and in combination with 10 mg montelukast, in subjects with asthma. Mannitol was inhaled in the dose that caused a 20% fall in FEV(1) on the screening day.[...]
|
|
|
J Asthma 2010,May,01;47(4):478-85; (PMID: 20528605)
BACKGROUND: Effective pediatric guideline-based asthma care requires the caregiver to accurately relay the child's symptom frequency, pattern of rescue and controller medication use, and level of [...]
|
|
|
J Med Assoc Thai 2010,May,01;93(5):541-9; (PMID: 20524439)
BACKGROUND: International asthma guideline recommends inhaled corticosteroids therapy for children of all ages as the first controller. However, in some less developed parts of the world, [...]
|
|
|
Respir Care 2010,May,01;55(5):536-43; (PMID: 20420722)
[...] (NIV) is an emerging modality in the management of patients with acute respiratory failure. However, its role in severe acute asthma is not well defined. OBJECTIVE: Evaluate the efficacy of NIV in severe acute asthma.[...]The baseline variables were similar in the 2 groups except for the mean duration of asthma, which was shorter in the standard-medical-therapy group. The median inspiratory and expiratory airway pressures applied were 12 cm [...]
|
 1 2 3 4 5 6 7 8 
|
|
|
|
|
